CAS 102767-28-2: Levetiracetam
Formula:C8H14N2O2
InChI:InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1
InChI key:InChIKey=HPHUVLMMVZITSG-LURJTMIESA-N
SMILES:[C@@H](C(N)=O)(CC)N1C(=O)CCC1
Synonyms:- (2S)-2-(2-oxopyrrolidin-1-yl)butanamide
- (S)-1-pyrrolidineacetamid
- 1-Pyrrolidineacetamide, α-ethyl-2-oxo-, (S)-
- Etiracetamum [INN-Latin]
- (S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide
- LEVITIRACETAM
- 1-Pyrrolidineacetamide, α-ethyl-2-oxo-, (αS)-
- Keppra
- (s)-2-(2-oxopyrrolidin-1-yl)butanamide
- alpha-Ethyl-2-oxo-1-pyrrolidineacetamide
- 1-Pyrrolidineacetamide
- See more synonyms
Sort by
Levetiracetam CRS
CAS:Levetiracetam CRSFormula:C8H14N2O2Color and Shape:White. Powder.Molecular weight:170.209Levetiracetam
CAS:Controlled ProductBinds vesicle protein SV2A to alter exocytosis; anti-epilepticFormula:C8H14N2O2Purity:Min. 97.5 Area-%Color and Shape:White Off-White PowderMolecular weight:170.21 g/molLevetiracetam
CAS:Applications The (S)-enantiomer of Etiracetam (E932970) and the ethyl analog of Piracetam (P500800). Used as an anticonvulsant. Neuroprotective & Neuroresearch Product. References Gower, A.J., et al.: Eur. J. Pharmacol., 222, 193 (1992); Kasteleijn-Noist Trenite, D.G.A., et al.: Epilepsy Res., 25, 225 (1996); Patsalos, P.N., et al.: Pharmacol. Ther., 85, 77 (2000)Formula:C8H14N2O2Color and Shape:WhiteMolecular weight:170.21Levetiracetam
CAS:Formula:C8H14N2O2Purity:≥ 98.0% (anhydrous basis)Color and Shape:White or almost white powderMolecular weight:170.21Levetiracetam
CAS:This Thermo Scientific Chemicals brand product was originally part of the Acros Organics product portfolio. Some documentation and label information may refer to the legacy brand. The original Acros Organics product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.Color and Shape:White to almost white, PowderLevetiracetam - Bio-X ™
CAS:Controlled ProductLevetiracetam is a modulates the activity of the synaptic vesicle protein 2A (SV2A) in the brain and is used to treat epilepsy.It is not clear exactly how Levetiracetam affects the activity of SV2A and if this is through inhibiting the release of neurotransmitters. However, it is thought to work by binding to a specific site on SV2A, which interferes with its normal function and ultimately leads to changes in exocytosis. One of the postulated mechanisms of action is that this modulates glutamate release. Levetiracetam is used to treat certain types of seizures in people with epilepsy. Levetiracetam is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready-to-use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.Formula:C8H14N2O2Purity:Min. 95%Color and Shape:PowderMolecular weight:170.21 g/mol(S)-2-(2-Oxopyrrolidin-1-yl)butanamide
CAS:Purity:95.0%Color and Shape:Solid, White powderMolecular weight:170.21200561523438Levetiracetam
CAS:Formula:C8H14N2O2Purity:>98.0%(HPLC)(N)Color and Shape:White to Almost white powder to crystalMolecular weight:170.21Levetiracetam
CAS:Levetiracetam (SIB-S1) is a relatively unique anticonvulsant that is typically used in combination with other antiepileptic medications for partial onsetFormula:C8H14N2O2Purity:98.37% - 99.67%Color and Shape:White Crystalline PowderMolecular weight:170.21
